R. Alan Chrusciel

584 total citations
14 papers, 375 citations indexed

About

R. Alan Chrusciel is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, R. Alan Chrusciel has authored 14 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Organic Chemistry and 5 papers in Infectious Diseases. Recurrent topics in R. Alan Chrusciel's work include Chemical Synthesis and Analysis (4 papers), HIV/AIDS drug development and treatment (4 papers) and Peptidase Inhibition and Analysis (3 papers). R. Alan Chrusciel is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), HIV/AIDS drug development and treatment (4 papers) and Peptidase Inhibition and Analysis (3 papers). R. Alan Chrusciel collaborates with scholars based in United States. R. Alan Chrusciel's co-authors include Joseph W. Strohbach, Michaël Kahn, Hiroshi Nakanishi, H. Uri Saragovi, Mark I. Greene, Michael E. Johnson, Karen R. Romines, Alice I. Sato, David B. Weiner and James A. Hoxie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Biotechnology.

In The Last Decade

R. Alan Chrusciel

14 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Alan Chrusciel United States 11 239 123 71 61 58 14 375
Thorsten Knöchel Germany 11 347 1.5× 84 0.7× 66 0.9× 49 0.8× 90 1.6× 11 535
Douglas A. Bergman Australia 12 358 1.5× 182 1.5× 83 1.2× 62 1.0× 43 0.7× 15 492
Michael D. Minnich United States 10 246 1.0× 93 0.8× 189 2.7× 161 2.6× 22 0.4× 15 481
David D. Deininger United States 9 216 0.9× 88 0.7× 186 2.6× 18 0.3× 24 0.4× 14 417
K. Meyer United States 10 177 0.7× 110 0.9× 72 1.0× 42 0.7× 24 0.4× 15 360
M. E. Marongiu Italy 13 156 0.7× 133 1.1× 152 2.1× 95 1.6× 12 0.2× 36 453
Kaname Kimura Japan 10 195 0.8× 99 0.8× 38 0.5× 30 0.5× 49 0.8× 15 364
Federica Orvieto Italy 11 227 0.9× 155 1.3× 129 1.8× 92 1.5× 27 0.5× 17 440
Stephen P. Edgcomb United States 7 296 1.2× 28 0.2× 34 0.5× 73 1.2× 25 0.4× 9 388
Christine Burlein United States 11 184 0.8× 144 1.2× 182 2.6× 61 1.0× 18 0.3× 18 449

Countries citing papers authored by R. Alan Chrusciel

Since Specialization
Citations

This map shows the geographic impact of R. Alan Chrusciel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Alan Chrusciel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Alan Chrusciel more than expected).

Fields of papers citing papers by R. Alan Chrusciel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Alan Chrusciel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Alan Chrusciel. The network helps show where R. Alan Chrusciel may publish in the future.

Co-authorship network of co-authors of R. Alan Chrusciel

This figure shows the co-authorship network connecting the top 25 collaborators of R. Alan Chrusciel. A scholar is included among the top collaborators of R. Alan Chrusciel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Alan Chrusciel. R. Alan Chrusciel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Blount, Ken, Cynthia M. Megyola, Mark S. Plummer, et al.. (2015). Novel Riboswitch-Binding Flavin Analog That Protects Mice against Clostridium difficile Infection without Inhibiting Cecal Flora. Antimicrobial Agents and Chemotherapy. 59(9). 5736–5746. 72 indexed citations
2.
Chrusciel, R. Alan & Joseph W. Strohbach. (2004). Non-Peptidic HIV Protease Inhibitors. Current Topics in Medicinal Chemistry. 4(10). 1097–1114. 44 indexed citations
3.
Judge, Thomas M., Joel Morris, Geoffrey P. Luke, et al.. (1997). Asymmetric Syntheses and Absolute Stereochemistry of 5,6-Dihydro-α-pyrones, A New Class of Potent HIV Protease Inhibitors. Journal of the American Chemical Society. 119(15). 3627–3628. 34 indexed citations
4.
Chrusciel, R. Alan & Karen R. Romines. (1997). Recent developments in HIV protease inhibitor research. Expert Opinion on Therapeutic Patents. 7(2). 111–121. 13 indexed citations
5.
Chrusciel, R. Alan, et al.. (1995). 4-Hydroxypyronesand Related Templatesas Nonpeptidic HIV Protease Inhibitors. Current Medicinal Chemistry. 2(4). 825–838. 35 indexed citations
6.
7.
Yee, Vivien C., et al.. (1993). The structure of a designed peptidomimetic inhibitor complex of α-thrombin. Protein Engineering Design and Selection. 6(5). 471–478. 17 indexed citations
8.
Nakanishi, Hiroshi, R. Alan Chrusciel, Stephen R. Bertenshaw, et al.. (1992). Peptide mimetics of the thrombin-bound structure of fibrinopeptide A.. Proceedings of the National Academy of Sciences. 89(5). 1705–1709. 14 indexed citations
9.
Nakanishi, Hiroshi, et al.. (1992). Design, synthesis and conformational analysis of γ-turn peptide mimetics of bradykinin. Biochemical and Biophysical Research Communications. 187(2). 999–1006. 33 indexed citations
10.
Saragovi, H. Uri, Mark I. Greene, R. Alan Chrusciel, & Michaël Kahn. (1992). Loops and Secondary Structure Mimetics: Development and Applications in Basic Science and Rational Drug Design. Nature Biotechnology. 10(7). 773–778. 40 indexed citations
11.
Chrusciel, R. Alan, Hiroshi Nakanishi, Michael E. Johnson, et al.. (1992). Design and synthesis of a CD4 beta-turn mimetic that inhibits human immunodeficiency virus envelope glycoprotein gp120 binding and infection of human lymphocytes.. Proceedings of the National Academy of Sciences. 89(13). 5872–5876. 55 indexed citations
12.
Kahn, Michaël, Hiroshi Nakanishi, R. Alan Chrusciel, Dennis Fitzpatrick, & Michael E. Johnson. (1991). Examination of HIV-1 protease secondary structure specificity using conformationally constrained inhibitors. Journal of Medicinal Chemistry. 34(12). 3395–3399. 13 indexed citations
13.
14.
Kahn, Michaël, et al.. (1991). A Mechanistic Revision Concerning an Apparent Intramolecular Azodicarbonyl Diels-Alder Reaction. Synlett. 1991(1). 31–32. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thorsten Knöchel Breakdown of academic impact, for papers by Douglas A. Bergman Breakdown of academic impact, for papers by Michael D. Minnich Breakdown of academic impact, for papers by David D. Deininger Breakdown of academic impact, for papers by K. Meyer Breakdown of academic impact, for papers by M. E. Marongiu Breakdown of academic impact, for papers by Kaname Kimura Breakdown of academic impact, for papers by Federica Orvieto Breakdown of academic impact, for papers by Stephen P. Edgcomb Breakdown of academic impact, for papers by Christine Burlein
Rankless by CCL
2026